Rosuvastatin Calcium/Telmisartan

瑞舒伐他汀钙/替米沙坦

Report date: 2022/02/11 16:40:43

Base Information

Drug NameRosuvastatin Calcium/Telmisartan
Drug Alias Name替米沙坦/瑞舒伐他汀钙Telmisartan/Rosuvastatin CalciumRosuvastatin/TelmisartanRosuvastatin Calcium and TelmisartanDuo Wellness +[9] 
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsHMG-CoA reductase inhibitors
TargetsAngiotensin II Receptor Type 1HMG-CoA reductase
Therapy Area/IndicationsHyperlipidemiasHypertension
Global Approved IndicationsHyperlipidemiasHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2015/01/01
Country/TerritorySouth Korea
CombinationsYes TelmisartanRosuvastatin Calcium
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesYuhan Corp
China Registration ClassN/A

Develop Information

Active CompaniesYuhan Corp
Inactive CompaniesN/A
Active IndicationsHyperlipidemiasHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09D
Related LinksN/A